14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.36 $1.36 Tuesday, 5th Dec 2023 BVXV stock ended at $1.36. During the day the stock fluctuated 0% from a day low at $1.36 to a day high of $1.36.
90 days $1.31 $1.36
52 weeks $1.25 $11.49

Historical BiondVax Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Oct 30, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 27, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 26, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 25, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 24, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 23, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 20, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 19, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 18, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 17, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 16, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 13, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 12, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 11, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 10, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 09, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 06, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 05, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 04, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 03, 2023 $1.36 $1.36 $1.36 $1.36 0
Oct 02, 2023 $1.36 $1.36 $1.36 $1.36 0
Sep 29, 2023 $1.36 $1.36 $1.36 $1.36 0
Sep 28, 2023 $1.36 $1.36 $1.36 $1.36 0
Sep 27, 2023 $1.36 $1.36 $1.36 $1.36 0
Sep 26, 2023 $1.36 $1.36 $1.36 $1.36 0
Click to get the best stock tips daily for free!

About BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development ... BVXV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT